Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Double Blind Study for the Treatment of Acute Ulcerative Colitis

ClinicalTrials.gov ID: NCT00350415

Public ClinicalTrials.gov record NCT00350415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, 6-week, Parallel-group Design Clinical Trial to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day for the Treatment of Moderately Active Ulcerative Colitis.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Double-blind, Randomized, 6-week, Parallel-group Design Clinical trial to assess the Safety and Efficacy of Asacol 4.8 g/day (800 mg mesalamine tablet) versus Asacol 2.4 g/day (400 mg mesalamine tablet) for the Treatment of Moderately Active Ulcerative Colitis (ASCEND III).

Study identification

NCT ID
NCT00350415
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
772 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
May 2007 (Actual)
Completion
May 2007 (Actual)
Last update posted
Apr 17, 2013

2006 – 2007

United States locations

U.S. sites
78
U.S. states
34
U.S. cities
77
Facility City State ZIP Site status
Research Facility Alabaster Alabama 35007 —
Research Facility Birmingham Alabama 35209 —
Research Facility Tucson Arizona 85712 —
Research Facility Fayetteville Arkansas 72703 —
Research Facility Little Rock Arkansas 72205 —
Research Facility Anaheim California 92801 —
Research Facility Burbank California 91505 —
Research Facility Encinitas California 93024 —
Research Facility Los Angeles California 90067 —
Research Facility Los Angeles California 90274 —
Research Facility Mission Hills California 91345 —
Research Facility Orange California 92868 —
Research Facility Pasadena California 91105 —
Research Facility Roseville California 95661 —
Research Facility Sacramento California 95825 —
Research Facility San Carlos California 94070 —
Research Facility San Francisco California 94115 —
Research Facility Lakewood Colorado 80215 —
Research Facility Littleton Colorado 80120 —
Research Facility Hamden Connecticut 06518-3691 —
Research Facility DeLand Florida 32720 —
Research Facility Harbor Village Florida 34684 —
Research Facility Hollywood Florida 33021 —
Research Facility Jacksonville Florida 32256 —
Research Facility Panama City Florida 33405 —
Research Facility Zephyrhills Florida 33542 —
Research Facility Atlanta Georgia 30033 —
Research Facility Savannah Georgia 31405 —
Research Facility Arlington Heights Illinois 60005 —
Research Facility Chicago Illinois 60637 —
Research Facility Topeka Kansas 60606 —
Research Facility Louisville Kentucky 40292 —
Research Facility Baton Rouge Louisiana 70809 —
Research Facility Shreveport Louisiana 71103 —
Research Facility Baltimore Maryland 21215 —
Research Facility Chevy Chase Maryland 20815 —
Research Facility Reisterstown Maryland 21136 —
Research Facility Boston Massachusetts 02115 —
Research Facility Columbia Michigan 65212 —
Research Facility Minneapolis Minnesota 55455 —
Research Facility Rochester Minnesota 55905 —
Research Facility Tupelo Mississippi 38801 —
Research Facility Kansas City Missouri 64131 —
Research Facility St Louis Missouri 63128 —
Research Facility Omaha Nebraska 68131 —
Research Facility Scottsbluff Nebraska 69361 —
Research Facility Egg Harbor New Jersey 08234 —
Research Facility Binghamton New York 13903 —
Research Facility Garden City New York 11530 —
Research Facility Great Neck New York 11021 —
Research Facility Huntington New York 11743 —
Research Facility New York New York 10021 —
Research Facility Rochester New York 14642 —
Research Facility Troy New York 12180 —
Research Facility Charlotte North Carolina 28262 —
Research Facility Wilmington North Carolina 28401 —
Research Facility Bismarck North Dakota 58501-1640 —
Research Facility Fargo North Dakota 58104 —
Research Facility Akron Ohio 44302 —
Research Facility Cincinnati Ohio 45242 —
Research Facility Dayton Ohio 45440 —
Research Facility Warren Ohio 44484 —
Research Facility Portland Oregon 97220 —
Research Facility Beaver Falls Pennsylvania 15010 —
Research Facility Philadelphia Pennsylvania 19107 —
Research Facility York Pennsylvania 17403 —
Research Facility Columbia South Carolina 29203 —
Research Facility Kingsport Tennessee 37660 —
Research Facility Memphis Tennessee 38120 —
Research Facility Nashville Tennessee 37232 —
Research Facility Austin Texas 78743 —
Research Facility San Antonio Texas 78205 —
Research Facility Murray Utah 84107 —
Research Facility Ogden Utah 84405 —
Research Facility Burlington Vermont 05401 —
Research Facility Chesapeake Virginia 23320 —
Research Facility Redmond Washington 98052 —
Research Facility Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00350415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2013 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00350415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →